Nuvaring and Salpingitis - a phase IV clinical study of FDA data

Summary:

Salpingitis is reported as a side effect among people who take Nuvaring (ethinyl estradiol; etonogestrel), especially for people who are 30-39 old, have been taking the drug for 1 - 6 months also take Coumadin, and have Menstruation irregular.

The phase IV clinical study analyzes which people have Salpingitis when taking Nuvaring. It is created by eHealthMe based on reports of 27,664 people who have side effects when taking Nuvaring from the FDA, and is updated regularly.

What is Nuvaring?

Nuvaring has active ingredients of ethinyl estradiol; etonogestrel. It is often used in birth control. eHealthMe is studying from 28,729 Nuvaring users. Check the latest studies of Nuvaring.

What is Salpingitis?

Salpingitis (an infection and inflammation in the fallopian tubes) is found to be associated with 158 drugs and 373 conditions by eHealthMe. Check the latest studies of Salpingitis.

On Jan, 06, 2026

27,664 people reported to have side effects when taking Nuvaring.
Among them, 36 people (0.13%) have Salpingitis.

Among these 36 people:

How long have people been on Nuvaring when they have Salpingitis? *

What is the age of people who have Salpingitis when taking Nuvaring? *

What are other drugs people take besides Nuvaring? *

What are other side effects people have besides Salpingitis? *

Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 11 people, 30.56%
Anaemia (lack of blood): 11 people, 30.56%
Tricuspid Valve Incompetence (inefficient heart valve): 10 people, 27.78%
Mitral Valve Incompetence (inefficient heart valve): 10 people, 27.78%
Pulmonary Embolism (blockage of the main artery of the lung): 9 people, 25.00%
Uterine Leiomyoma (uterine benign tumour derived from smooth muscle): 7 people, 19.44%
Left Ventricular Hypertrophy (the thickening of the myocardium (muscle) of the left ventricle of the heart): 7 people, 19.44%
Pulmonary Valve Incompetence: 6 people, 16.67%
Pulmonary Infarction (death of a small area of lung): 6 people, 16.67%
Ovarian Cysts (fluid filled sacs of the ovary): 6 people, 16.67%

What are the existing conditions these people have? *

Menstruation Irregular: 6 people, 16.67%
Pulmonary Embolism (blockage of the main artery of the lung): 3 people, 8.33%
Hot Flush (sudden feelings of heat): 2 people, 5.56%
Endometriosis (appearance of endometrial tissue outside the uterus and causing pelvic pain): 2 people, 5.56%
Thrombosis (formation of a blood clot inside a blood vessel): 1 person, 2.78%
Migraine (headache): 1 person, 2.78%

* Approximation only. Some reports may have incomplete information.

Do you take Nuvaring and have Salpingitis?

- Check whether Salpingitis is associated with a drug or a condition (FREE)
- Predict drug outcomes for up to one year with AI (FREE)
- Get an AI agent to monitor your drugs continuously (FREE)

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nuvaring:

Nuvaring (28,729 reports)

Salpingitis treatments and more:

Salpingitis (862 reports)

How severe was Salpingitis and when was it recovered:

Salpingitis in Nuvaring

Expand to all the drugs that have ingredients of ethinyl estradiol; etonogestrel:

Salpingitis and drugs with ingredients of ethinyl estradiol; etonogestrel (36 reports)

Sub-studies by age:

0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Nuvaring:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Salpingitis:

Salpingitis (158 drugs)

Browse all the conditions that are associated with Salpingitis:

Salpingitis (373 conditions)

Drugs similar to Nuvaring and Salpingitis :

How the study uses the data?

The study uses data from the FDA. It is based on ethinyl estradiol; etonogestrel (the active ingredients of Nuvaring) and Nuvaring (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.